Complement C5a Receptors in Hidradenitis Suppurativa

 

Actual Study Start Date:

July 18, 2019

Estimated Primary Completion Date: January 20, 2021

Estimated Study Completion Date: July 20, 2021

​

ID#NCT04251663

 

Sponsor: Stanford University

Information provided by (Responsible Party): Kavita Sarin, Stanford University

 

Brief Summary:

​

To study the role of C5a in Hidradenitis Suppurativa (HS). Complement C5a is a major chemotactic factor that stimulates neutrophil infiltration.

 

Study Type: Observational

Estimated Enrollment: 20 participants

 

Complete details to the study link:

 

https://clinicaltrials.gov/ct2/show/NCT04251663?recrs=a&cond=Hidradenitis&draw=2&rank=9

 

Location:

Redwood City, California, 94063

 

Contact: 

Clinical Trial Coordinator 650-721-7149